Lead Product(s) : Lidocaine Hydrochloride
Therapeutic Area : Dental and Oral Health
Study Phase : Phase IV
Sponsor : Anfomed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 27, 2017
Lead Product(s) : Lidocaine Hydrochloride
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase IV
Sponsor : Anfomed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fluorophosphate
Therapeutic Area : Dental and Oral Health
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparative Efficacy of Floss vs Essential Oil/CPC+Zn in Reducing Plaque & Gingivitis
Details : Sodium Monofluorophosphate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Dental Plaque.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
June 19, 2025
Lead Product(s) : Fluorophosphate
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tin Fluoride
Therapeutic Area : Dental and Oral Health
Study Phase : Phase IV
Sponsor : University of Texas Health Science Center at Houston
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 12, 2025
Lead Product(s) : Tin Fluoride
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase IV
Sponsor : University of Texas Health Science Center at Houston
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dentifrice
Therapeutic Area : Dental and Oral Health
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
September 23, 2024
Lead Product(s) : Dentifrice
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sodium Fluoride
Therapeutic Area : Dental and Oral Health
Study Phase : Phase IV
Sponsor : 3M ESPE | SDI Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 16, 2023
Lead Product(s) : Sodium Fluoride
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase IV
Sponsor : 3M ESPE | SDI Limited
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tin Fluoride
Therapeutic Area : Dental and Oral Health
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Study to Assess Therapeutic Delay and Resolution of Induced Gingivitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 16, 2023
Lead Product(s) : Tin Fluoride
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Tin Fluoride
Therapeutic Area : Dental and Oral Health
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Fluoride Dose Response Using In Situ Caries Model
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 21, 2021
Lead Product(s) : Tin Fluoride
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Trichloroacetic Acid
Therapeutic Area : Dental and Oral Health
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 08, 2021
Lead Product(s) : Trichloroacetic Acid
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Markman Biologics Microsurfaced Adm
Therapeutic Area : Dental and Oral Health
Study Phase : Phase IV
Sponsor : CellTherX
Deal Size : Inapplicable
Deal Type : Inapplicable
Pilot Study for Healing and Safety Outcomes in Gingival Recession
Details : Undisclosed
Product Name : Undisclosed
Product Type : Microorganism
Upfront Cash : Inapplicable
November 04, 2020
Lead Product(s) : Markman Biologics Microsurfaced Adm
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase IV
Sponsor : CellTherX
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Levofloxacin
Therapeutic Area : Dental and Oral Health
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of CKI for Oral Mucositis Caused by Radiotherapy for Head and Neck Cancer
Details : Undisclosed
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
December 19, 2019
Lead Product(s) : Levofloxacin
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable